European Society of Cardiology: Cardiovascular Disease Statistics 2017.

By A. Timmis, N. Townsend, C. Gale, R. Grobbee, N. Maniadakis, M. Flather, Elizabeth Wilkins, L. Wright, R. Vos, Jeroen J. Bax and 3 more. European Heart Journal, 2018

727 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/72f740a1e67912bc280d17e0e64662a209f36286

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. I. Graham
2. Rhian M. Touyz
3. F. Mach
4. C. Baigent
5. B. Ference
6. Alberico L. Catapano
7. V. Aboyans
8. J. Collet

Citations in the corpus

• A population-based study of cardiovascular disease mortality risk in US cancer patients. (2019, background): “Populations with low SES are more likely to have cancer and SES disparity may continue to contribute to CVD mortality risk in cancer survivors.(37,38) In line with these limitations, it is acknowledged that the SEER database does not provide information on comorbidities or modifiable risk factors.”
• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019, background): “This would address the persistent socio-economic divide in CV health despite major improvements in ASCVD treatment.(558) More than one-half of the reduction in CV mortality over the last three decades has been attributed to population-level changes in CV risk factors, primarily reductions in plasma ”